Dosage and administration
Adults only: 1 capsule daily between meals, orally. Not recommended in children.
Adults only: 1 capsule daily between meals, orally. Not recommended in children.
Iron 106 mg, Sodium Ascorbate 200 mg, Thiamine 10 mg, Riboflavin 6 mg, Pyridoxine 5 mg, Folic Acid 1 mg, Cyanocobalamin 15 mcg, Niacinamide 30 mg, Pantothenic Acid 10 mg, Zinc 18.2 mg, Magnesium 6.9 mg
| Copper (Copper sulfate) | 0.8 mg |
| Manganese (Manganese Sulfate) | 1.3 mg |
A medical food, for use only under the direction and supervision of a licensed physician.
RX only
| Ferrous Fumerate | 106 mg(Iron) |
| Vitamin C (Sodium Ascorbate) | 200 mg |
| Vitamin B1 (Thiamine Mononitrate) | 10 mg |
| Vitamin B2 (Riboflavin) | 6 mg |
| Vitamin B6 (Pyridoxine HCL) | 5 mg |
| Folic Acid | 1 mg |
| Vitamin B12 | 15 mcg |
| Niacinamide | 30 mg |
| Pantothenic Acid | 10 mg |
| Zinc (Zinc Sulfate) | 18.2 mg |
| Magnesium (Magnesium Sulfate) | 6.9 mg |
| Copper (Copper Sulfate) | 0.8 mg |
| Manganese (Manganese Sulfate) | 1.3 mg |
Microcrystalline Cellulose, Silica, Magnesium Stearate, Gelatin Capsule
For the treatment of anemia due to lack of iron and low folate as in menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. Also for treatment of conditions where iron and vitamin C deficiency occur together, along with a poor intake or increased need for B-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in periods of extended recovery.
Centratex is contraindicated in patients with a known hypersensitivity to any of its ingredients. Iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, and hemolytic anemias. Folic acid may obscure signs and symptoms of pernicious anemia and is therefore a contraindication as well.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. Iron is toxic and has been shown to cause severe reactions in children including death.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B-12 is deficient.
Folic acid in doses above 0.1 mg – 0.4 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.
Safety and effectiveness in pediatric patients has not been established.
No clinical studies have been performed in patients over 65 to determine whether older persons respond differently from younger persons. Physicians should consider that elderly persons may have decreased hepatic, renal, or cardiac function.
Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and subside with continuation of therapy and physician encouragement. Although the absorption of iron is best when taken between meals, occasional G.I. disturbances may be controlled by giving Centratex shortly after meals.
Adults only: 1 capsule daily between meals, orally. Not recommended in children.
Centratex is supplied as a natural gelatin capsule with tan speckled powder. Centratex is available in bottles of 100 (NDC 23359-100-10) and bottles of 30 (NDC 23359-100-30) Dispense in a tight, light resistant container as defined in the USP/NF with a child resistant closure. Store at room temperature between 15-30 degrees C (59-86 degrees F) Keep in a cool, dry place.
RX ONLY
Centurion Labs, LLC
Birmingham, AL 35243
Rev. 8/17
NDC 23359-100-30
Centratex
| Iron (Ferrous Fumarate, anhydrous | 106 mg |
| Vitamin C (Sodium Ascorbate) | 200 mg |
| Vitamin B1 (Thiamine Mononitrate) | 10 mg |
| Vitamin B2 (Riboflavin) | 6 mg |
| Vitamin B6 (Pyridoxine HCl) | 5 mg |
| Vitamin B12 (Cyanocobalamin Concentrate) | 15 mcg |
| Folic Acid | 1 mg |
| Niacinamide (Nicotinamide) | 30 mg |
| Pantothenic Acid (Calcium Pantothenate) | 10 mg |
| Zinc (Zinc Sulfate) | 18.2 mg |
| Magnesium (Magnesium Sulfate) | 6.9 mg |
| Manganese (Manganese Sulfate) | 1.3 mg |
| Copper (Cupric Sulfate) | 0.8 mg |
CENTURION LABS Rx Only
Net Contents: 30 capsules
NDC 23359-100-10
Centratex
| Iron (Ferrous Fumarate, anhydrous) | 106 mg |
| Vitamin C (Sodium Ascorbate) | 200 mg |
| Vitamin B1 (Thiamine Mononitrate) | 10 mg |
| Vitamin B2 (Riboflavin) | 6 mg |
| Vitamin B6 (Pyridoxine HCl) | 5 mg |
| Vitamin B12 (Cyanocobalamin Concentrate) | 15 mcg |
| Folic Acid | 1 mg |
| Niacinamide (Nicotinamide) | 30 mg |
| Pantothenic Acid (Calcium Pantothenate) | 10 mg |
| Zinc (Zinc Sulfate) | 18.2 mg |
| Magnesium (Magnesium Sulfate) | 6.9 mg |
| Manganese (Manganese Sulfate) | 1.3 mg |
| Copper (Copper Sulfate) | 0.8 mg |
CENTURION LABS
Rx Only
Net Contents: 100 capsules

| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| MANGANESE CATION (2+) Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 23359-100-10 | 2024-07-30 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| 23359-100-30 | 2024-07-30 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| 23359-100-10 | 2024-01-31 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| 23359-100-30 | 2024-01-31 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| 23359-100-10 | 2019-12-20 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| 23359-100-30 | 2019-12-20 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| 23359-100-10 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| 23359-100-30 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c1a1-621f-e053-dbdaa90a74ad | Centratex Capsules |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23359-100-10 | Centratex | 100 in 1 BOTTLE | CAPSULE | 100 | 4 | |
| 23359-100-30 | Centratex | 30 in 1 BOTTLE | CAPSULE | 30 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 23359-100 | CENTRATEX (IRON, SODIUM ASCORBATE, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, NIACINAMIDE, CALCIUM PANTOTHENATE, ZINC SULFATE, MAGNESIUM SULFATE, MANGANESE SULFATE, AND CUPRIC SULFATE ANHYDROUS) CAPSULE [CENTURION LABS, LLC] | 4 | Legacy NDC, 2 package rows | 20240202_4d4d823b-ff2f-4746-9bd7-44def2b81347.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23359-100-10 | EA - Each | 23359-100 | d4dcd3d1-3d6b-423f-9959-5f2cdccded2f | 1 | 2012-07-24 |
| 23359-100-30 | EA - Each | 23359-100 | cf810c9d-80a3-4a4e-a49b-6eebb2531e38 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Calcium Pantothenate | ACTIVE INGREDIENT | 568ET80C3D | 1 | |
| Cupric Sulfate Anhydrous | ACTIVE INGREDIENT | KUW2Q3U1VV | 1 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| Iron | ACTIVE INGREDIENT | E1UOL152H7 | 1 | |
| Magnesium Sulfate | ACTIVE INGREDIENT | DE08037SAB | 1 | |
| Manganese Sulfate | ACTIVE INGREDIENT | W00LYS4T26 | 1 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| Pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| Sodium Ascorbate | ACTIVE INGREDIENT | S033EH8359 | 1 | |
| Thiamine Mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 1 | |
| Zinc Sulfate | ACTIVE INGREDIENT | 89DS0H96TB | 1 | |
| Copper | ACTIVE MOIETY | 789U1901C5 | 1 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| Iron | ACTIVE MOIETY | E1UOL152H7 | 1 | |
| Magnesium | ACTIVE MOIETY | I38ZP9992A | 1 | |
| Manganese | ACTIVE MOIETY | 42Z2K6ZL8P | 1 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| Pantothenic Acid | ACTIVE MOIETY | 19F5HK2737 | 1 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 1 | |
| Sodium Cation | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| Thiamine | ACTIVE MOIETY | X66NSO3N35 | 1 | |
| zinc | ACTIVE MOIETY | J41CSQ7QDS | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 23359-100 | 23359-100-10, 23359-100-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| GELATIN | 2G86QN327L | IACT |
| IRON | E1UOL152H7 | ACTIB |
| SODIUM ASCORBATE | S033EH8359 | ACTIM |
| THIAMINE MONONITRATE | 8K0I04919X | ACTIR |
| RIBOFLAVIN | TLM2976OFR | ACTIB |
| PYRIDOXINE HYDROCHLORIDE | 68Y4CF58BV | ACTIB |
| FOLIC ACID | 935E97BOY8 | ACTIB |
| CYANOCOBALAMIN | P6YC3EG204 | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| CALCIUM PANTOTHENATE | 568ET80C3D | ACTIM |
| ZINC SULFATE | 89DS0H96TB | ACTIM |
| MAGNESIUM SULFATE, UNSPECIFIED | DE08037SAB | ACTIB |
| MANGANESE SULFATE | W00LYS4T26 | ACTIM |
| CUPRIC SULFATE ANHYDROUS | KUW2Q3U1VV | ACTIM |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, SUGAR COATED / ORAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, SUSPENSION / INTRAMUSCULAR | 1.3 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 14 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Gelatin | GELATIN | 2G86QN327L | SOLUTION / INTRAVENOUS | 34.8 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRACAVITARY | 0.05 ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| Gelatin | GELATIN | 2G86QN327L | WAFER / ORAL | NA | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / ORAL | 120 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, COATED / ORAL | 42.12 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| Gelatin | GELATIN | 2G86QN327L | PASTILLE / ORAL | 143 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 14 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRAMUSCULAR | 16 %w/v | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED / ORAL | 288 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | 13 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, DELAYED RELEASE / ORAL | 19 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0aacf4b2-45ad-beb2-e063-6394a90ae53c | 4d4d823b-ff2f-4746-9bd7-44def2b81347 | 2024-01-31 | Warnings, Adverse reactions | 0aacf4b2-45ad-beb2-e063-6394a90ae53c 4d4d823b-ff2f-4746-9bd7-44def2b81347 |
Adverse event summaries are temporarily unavailable. Other product information remains available.